Floatz logo

Clofarabine

Transplantation Infection

Targazyme, Inc.Small moleculePhase 3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

14 Active assets in the Transplantation Infection cohort.

Asset / SponsorPhaseRating
TACROLIMUS
University of Illinois at Chicago
Phase 4BBB
CYCLOSPORIN A
Fernanda P Silveira, MD, MS
Phase 4BBB
Rapamycin
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 4BBB
Busulphan
M.D. Anderson Cancer Center
Phase 3BB
Fludarabine
M.D. Anderson Cancer Center
Phase 3BB

View all 33 →

Same molecule, other indications

Clofarabine is also rated in:

acute myeloid leukemia with 11q23 abnormalitiesDormant
BB
Indicative ·
70 / 100
View asset →
acute myeloid leukemia, del(5q31-q32)Dormant
BB
Indicative ·
70 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →